181 related articles for article (PubMed ID: 37615813)
1. Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India.
Dominic N; Sharma L; Mohindra N; Dabadghao P
Endocrine; 2023 Nov; 82(2):303-310. PubMed ID: 37615813
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
3. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
Łebkowska A; Adamska A; Krentowska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Hryniewicka J; Leśniewska M; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
J Clin Endocrinol Metab; 2021 May; 106(6):1811-1820. PubMed ID: 33537700
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
Escobar-Morreale HF; Roldán B; Barrio R; Alonso M; Sancho J; de la Calle H; García-Robles R
J Clin Endocrinol Metab; 2000 Nov; 85(11):4182-7. PubMed ID: 11095451
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy.
Zachurzok A; Deja G; Gawlik A; Drosdzol-Cop A; Małecka-Tendera E
Endokrynol Pol; 2013; 64(2):121-8. PubMed ID: 23653275
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
[TBL] [Abstract][Full Text] [Related]
9. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes.
García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A
Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088
[TBL] [Abstract][Full Text] [Related]
10. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
Escobar-Morreale HF; Roldán-Martín MB
Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
14. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
15. Menstrual Disorders and Androgen-Related Traits in Young Women with Type 1 Diabetes Mellitus: a Clinical Study.
Paschou SA; Vryonidou A; Melissourgou M; Kosteria I; Goulis D; Chrousos GP; Kanaka-Gantenbein C
Endocr Pract; 2020 Nov; 26(11):1269-1276. PubMed ID: 33471656
[TBL] [Abstract][Full Text] [Related]
16. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
17. Ovarian functions and polycystic ovary syndrome in adult women with type 1 diabetes mellitus in a Turkish population.
Urhan E; Elbuken G; Hacioglu A; Karaca Z; Unluhizarci K; Kelestimur F
J Endocrinol Invest; 2023 Mar; 46(3):609-616. PubMed ID: 36308639
[TBL] [Abstract][Full Text] [Related]
18. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus.
Codner E; Escobar-Morreale HF
J Clin Endocrinol Metab; 2007 Apr; 92(4):1209-16. PubMed ID: 17284617
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
